Average Insider

Where insiders trade, we follow

$DYN
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Healthcare
Sector
Biotechnology
Industry
John G. Cox
CEO
192
Employees
$17.56
Current Price
$2.47B
Market Cap
52W Low$6.36
Current$17.5660.1% above low, 39.9% below high
52W High$25.00

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys11$38,700.002,0001:405.16
Sells15$15,679,875.76818,460
1 monthBuys12$83,880.005,0001:187.60
Sells48$15,736,257.36822,244
2 monthsBuys12$83,880.005,0001:187.60
Sells48$15,736,257.36822,244
3 monthsBuys12$83,880.005,0001:187.60
Sells48$15,736,257.36822,244
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Mar 11, 2026
Posner Brian S
Director
Purchase2,000$19.35$38,700.00View Details
Mar 11, 2026
Kersten Dirk
Director
Sale129,672$19.52$2,530,562.05View Details
Mar 9, 2026
Kersten Dirk
Director
Sale177,690$17.72$3,148,986.64View Details
Mar 10, 2026
Kersten Dirk
Director
Sale9,482$18.21$172,687.13View Details
Mar 10, 2026
Kersten Dirk
Director
Sale219,758$19.32$4,246,823.35View Details
Mar 10, 2026
Kersten Dirk
Director
Sale281,858$19.80$5,580,816.59View Details
Mar 6, 2026
Posner Brian S
Director
Purchase3,000$15.06$45,180.00View Details
Mar 5, 2026
Kerr Douglas
Chief Medical Officer
Sale904$14.90$13,469.60View Details
Mar 5, 2026
Cox John
Director
Sale2,732$14.90$40,706.80View Details
Mar 5, 2026
Friedl-Naderer Johanna
Chief Commercial Officer
Sale148$14.90$2,205.20View Details
12 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
May 6, 2026
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A

Past Earnings

Historical earnings results
Feb 26, 2026
EPS
Estimated-$0.74
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ€” create a free account to see 12 months of history

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.3.23